Evidence map›Paper›PMID 25160001›Full record

ArticleNeurotoxicology2014

Synergistic effects on dopamine cell death in a Drosophila model of chronic toxin exposure.

Ciara A Martin, Angel Barajas, George Lawless, Hakeem O Lawal, Khadij Assani, Yosephine P Lumintang, Vanessa Nunez, David E Krantz

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. International journal of molecular sciences · 2018
    Review
  6. The road less traveled: from genotype to phenotype in flies and humans.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ciara A MartinUCLA Interdepartmental Program in Molecular Toxicology, Los Angeles, CA 90095, United States. Electronic address: martin.ciaraann@gmail.com.
Angel BarajasDepartment of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: a.barajas40@gmail.com.
George LawlessDepartment of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: glawless@ucla.edu.
Hakeem O LawalUCLA Interdepartmental Program in Molecular Toxicology, Los Angeles, CA 90095, United States; Department of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: hakeemlawal@gmail.com.
Khadij AssaniDepartment of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: khadij.assani@gmail.com.
Yosephine P LumintangDepartment of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: y.lumintang@yahoo.com.
Vanessa NunezDepartment of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: vnunez16@ucla.edu.
David E KrantzUCLA Interdepartmental Program in Molecular Toxicology, Los Angeles, CA 90095, United States; Department of Psychiatry and Biobehavioral Sciences, The Gonda (Goldschmied) Neuroscience and Genetics Research Center, Room 3335, Hatos Center For Neuropharmacology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Los Angeles, CA 90095, United States. Electronic address: dkrantz@ucla.edu.
University of California, Los Angeles · US

Funding

Updated confocal microscope in the Imaging Core facility to support biomedical researchP20GM103653 · NIGMS · DELAWARE STATE UNIVERSITY · PI HARRINGTON, MELISSA A · 2012 to 2022
$22.7M
UCLA MSD ProgramR25GM055052 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BARBER, PAUL HENRY, HASSON, TAMA W. · 1996 to 2021
$9.2M
Project 4: Pesticides and Genes In PD: Studies In HumansP01ES016732 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRONSTEIN, JEFF MICHAEL · 2008 to 2012
$6.7M
Training in Molecular ToxicologyT32ES015457 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ALLARD, PATRICK, HANKINSON, OLIVER NMN · 2008 to 2025
$4.0M
Environmental toxin interactions with genetic risks for Parkinson's diseaseR01ES015747 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRANTZ, DAVID EVAN · 2007 to 2011
$2.1M
Trafficking of the Drosophila Vesicular Monoamine TransporterR01MH076900 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KRANTZ, DAVID EVAN · 2007 to 2011
$1.5M
NIEHS NIH HHS ES016732NIEHS NIH HHS P01 ES016732NIEHS NIH HHS R01 ES015747NIEHS NIH HHS T32 ES015457NIGMS NIH HHS P20 GM103653NIGMS NIH HHS R25 GM055052NIMH NIH HHS R01 MH076900
6 · The paper itself

Abstract

The neurodegenerative effects of Parkinson's disease (PD) are marked by a selective loss of dopaminergic (DA) neurons. Epidemiological studies suggest that chronic exposure to the pesticide paraquat may increase the risk for PD and DA cell loss. However, combined exposure with additional fungicide(s) including maneb and/or ziram may be required for pathogenesis. To explore potential pathogenic mechanisms, we have developed a Drosophila model of chronic paraquat exposure. We find that while chronic paraquat exposure alone decreased organismal survival and motor function, combined chronic exposure to both paraquat and maneb was required for DA cell death in the fly. To initiate mechanistic studies of this interaction, we used additional genetic reagents to target the ubiquitin proteasome system, which has been implicated in some rare familial forms of PD and the toxic effects of ziram. Genetic inhibition of E1 ubiquitin ligase, but not the proteasome itself, increased DA cell death in combination with maneb but not paraquat. These studies establish a model for long-term exposure to multiple pesticides, and support the idea that pesticide interactions relevant to PD may involve inhibition of protein ubiquitination.

Indexed as

AnimalsCell DeathDisease Models, AnimalDopaminergic NeuronsDrosophila melanogasterManebMotor ActivityParaquatParkinson Disease, SecondaryPesticidesSurvival AnalysisUbiquitin-Protein LigasesZiramManebParaquatPesticidesUbiquitin-Protein LigasesZiramE1 ligaseManebParaquatParkinson's diseaseUbiquitin proteasome systemZiram

Identifiers

PMID25160001
PMCPMC4264678
OpenAlexW2071280955

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.